Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs is a research paper published in JAMA Network Open (2023). On theSindex it has a DataRank of 0. It has been cited 71 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR003142
NIAMS NIH HHS
Grant: R01 AR078268
NIAID NIH HHS
Grant: U01 AI101981
National Institutes of Health
Grant: 5UL1TR003142-03
Stanford Center for Clinical & Translational Education and Research (Spectrum)
National Institutes of Health
Grant: 5U01AI101981-09
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis
National Institutes of Health
Grant: 5R01AR078268-02
Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis
National Institutes of Health
Grant: 5R25AI147369-02
Stanford TRANSFORM I2T Program
Fields of Study
MeSH Terms
Keywords